Welcome to Synolus Medical
Synolus Medical, Inc is a leading biopharmacuetical device company focused on developing and commercializing advanced drug delivery systems which address unmets needs in administration of injectable drugs. Rising chronic disease is a major global problem. An estimated 1 and 10 individuals suffer from chronic conditions which can be treated by injection therapy. This ratio increases to closer to 1 in 4 in the aging population. Synolus Medical is developing MiniGo, a prefilled, preassembled, simple to use and ultra-compact wearable injection device enabling on-the-go patient treatment which creates better patient adherence and better health outcome and reduces healthcare costs.
- The use of injectable biologic drugs has brought significant advances in the treatment of autoimmune diseases like rhemoatoid arthritis, multiple-sclerosis, and psoriasis, as well as cardiovascular disease and cancer. These drugs can offer tremendous therapuetic benefit to patients, but receiving the injection through traditional means (e.g., syringes, autoinjectors, infusion clinics) can be painful or impractical due to the higher dose volume, higher viscosity, and other factors. An estimated 50% avoid injections or fail to adhere to treatment due to fear and anxiety of injection, negative social stigma associated with injections, or inability to visit clinics frequently. This non-adherence to treatment problem costs the healthcare system an estimated $100B annually. Synolus aims to help solve this problem by introducing innovative treatment enhancing products to patients.
- We provides compelling differentiation for our pharma partners enabling them to increase market share and revenues, while simultaneously providing significant health and lifestyle benefits to patients. Synolus creates benefit for the patient, the prescriber, the pharma provider and the healthcare system. Whilst doing so, Synolus recognizes that life enhancing therapies and technologies only benefit patients if they can be successfully commercialized. Therefore, innovation in solving manufacturability challenges has been at the forefront of Synolus’ development efforts, for a true all around complete solution in MiniGo.
Synolus is currently seeking investment and partnership to further develop its products and technology and ulimately bring them to market to serve patients. More information on Synolus Medical is coming soon! Thank your for reading, and for additional information now please don't hesitate to contact us!